Measurement of glomerular filtration rate using dynamic magnetic resonance imaging in patients with chronic kidney disease

Journal of Nephrology

Volumn 24, Issue 4, 2011, Pages 482-489

  Artunc, Ferruh ^a   Yildiz, Serdar ^a   Boss, Andreas ^a   Frenzel, Thomas ^b   Schlemmer, Heinz Peter ^a   Schick, Fritz ^a   Risler, Teut ^a   Häring, Hans Ulrich ^a   Rossi, Cristina ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Gadobutrol; Glomerular filtration rate; Magnetic resonance imaging

Indexed keywords

GADOBUTROL;

ACCURACY; ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INULIN CLEARANCE; LOW DRUG DOSE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CLEARANCE;

CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INULIN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RENAL INSUFFICIENCY, CHRONIC;

EID: 79960322491     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2010.5978     Document Type: Article

References (24)

1. Cirillo M. Evaluation of glomerular filtration rate and of albuminuria/ proteinuria. J Nephrol. 2010;23:125-132.
2. Stevens LA, Levey AA. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009;20:2305-2313.
3. Levey AS, Coresh J, Greene T, et al. Expressing the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766-772.
4. Carnevale V, Pastore L, Camaioni M, et al. Estimate of renal function in oldest old inpatients by MDRD study equation, Mayo Clinic equation and creatinine clearance. J Nephrol. 2010;23:306-313.
5. Coresh J, Stevens LA. Kidney function estimating equations: where do we stand? Curr Opin Nephrol Hypertens. 2006;15:276-284.
6. Hackstein N, Kooijman H, Tomaselli S, Rau WS. Glomerular filtration rate measured using the Patlak plot technique and contrast-enhanced dynamic MRI with different amounts of gadolinium-DTPA. J Magn Reson Imaging. 2005;22:406-414.
7. Lee VS, Rusinek H, Noz ME, Lee P, Raghavan M, Kramer EL. Dynamic three-dimensional MR renography for the measurement of single kidney function: initial experience. Radiology. 2003;227:289-294.
8. Bokacheva L, Rusinek H, Zhang JL, Chen Q, Lee VS. Estimates of glomerular filtration rate from MR renography and tracer kinetic models. J Magn Reson Imaging. 2009;29:371-382.
9. Boss A, Martirosian P, Gehrmann M, et al. Quantitative assessment of glomerular filtration rate with MR gadolinium slope clearance measurements. Radiology. 2007;242:783-790.
10. Staks T, Schuhmann-Giampieri G, Frenzel T, Weinmann HJ, Lange L, Platzek J. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers. Invest Radiol. 1994;29:709-715.
11. Prasad PV. Functional MRI of the kidney: tools for translational studies of pathophysiology of renal disease. Am J Physiol Renal Physiol. 2006;290:F958-F974.
12. Choyke PL, Austin HA, Frank JA, et al. Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. Kidney Int. 1992;41:1595-1598.
13. Rusinek H, Lee VS, Johnson G. Optimal dose of Gd-DTPA in dynamic MR studies. Magn Reson Med. 2001;46:312-316.
14. Gates GF. Glomerular filtration rate: estimation from fractional accumulation of Tc-99m DTPA (stannous). AJR Am J Roentgenol. 1982;138:565-570.
15. Boss A, Schaefer JF, Martirosian P, et al. Contrast-enhanced dynamic MR nephrography using the Turbo-FLASH navigator-gating technique in children. Eur Radiol. 2006;16:1509-1518.
16. Boss A, Martirosian P, Schaefer JF, et al. Dynamic magnetic resonance nephrography: is saturation recovery TrueFISP advantageous over saturation recovery TurboFLASH? Invest Radiol. 2007;42:256-262.
17. Peters AM. The kinetic basis of glomerular filtration rate measurement and new concepts of indexation to body size. Eur J Nucl Med Mol Imaging. 2004;31:137-149.
18. Gunasekera RD, Allison DJ, Peters AM. Glomerular filtration rate in relation to extracellular fluid volume: similarity between 99mTc-DTPA and inulin. Eur J Nucl Med. 1996;23:49-54.
19. Roe JH, Epstein JH, Goldstein NP. A photometric method for the determination of inulin in plasma and urine. J Biol Chem. 1949;178:839-845.
20. Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest. 1972;30:271-274.
21. Artunc F, Yildiz S, Rossi C, et al. Simultaneous evaluation of renal morphology and function in live kidney donors using dynamic magnetic resonance imaging. Nephrol Dial Transplant. 2010;25:1986-91.
22. Grobner T. Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21:1104-1108.
23. Thomsen HS, Marckmann P, Logager VB. Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging. 2007;7:130-137.
24. Perazella MA. Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis. Curr Drug Saf. 2008;3:67-75.